Are we ready for caries prevention through bacteriotherapy? by Twetman, Svante
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Are we ready for caries prevention through bacteriotherapy?
Twetman, Svante
Published in:
Brazilian Oral Research
DOI:
10.1590/S1806-83242012000700010
Publication date:
2012
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY-NC
Citation for published version (APA):
Twetman, S. (2012). Are we ready for caries prevention through bacteriotherapy? Brazilian Oral Research,
26(spec. iss. 1), 64-70. https://doi.org/10.1590/S1806-83242012000700010
Download date: 03. Feb. 2020
Cariology
64 Braz Oral Res., (São Paulo) 2012;26(Spec Iss 1):64-70
Svante Twetman
	 	Department	of	Odontology,	Section	for	
Cariology,	Endodontics,	Pediatric	Dentistry	
and	Clinical	Genetics,	Faculty	of	Health	
and	Medical	Sciences,	University	of	
Copenhagen,	Copenhagen,	Denmark.
Cariology
Corresponding Author: 
Svante	Twetman	
E-mail:	stwe@sund.ku.dk
Are we ready for caries prevention 
through bacteriotherapy?
Abstract: Recent insights in medical science indicate that human biofilms 
play an important role in health and well-being, and have put microbiota 
modulation through bacteriotherapy into focus. In dentistry, bacterial in-
terference with probiotic bacteria to support the stability and diversity 
of oral biofilms has gained similar interest. Investigations in vitro into 
metabolic activity, co-aggregation, growth inhibition, bacteriocin pro-
duction, and adhesion have collectively suggested a potential role for pro-
biotic lactobacilli and bifidobacteria to modulate the oral microbial ecol-
ogy. Likewise, short-term clinical studies with intermediate microbial 
endpoints indicate that interference with caries-associated bacteria seems 
possible through probiotic dairy products, tablets, lozenges and chewing 
gum in various dose regimens. Few randomized controlled clinical tri-
als with caries outcomes are available, but three studies with preschool 
children and the elderly have demonstrated preventive fractions between 
21% and 75%, following regular intake of milk supplemented with pro-
biotic lactobacilli. However, further large-scale trials with orally derived 
anti-caries candidates are needed before we can say that we are ready for 
bacteriotherapy as an adjunct to complement the existing evidence-based 
methods for preventing and controlling caries in daily practice.
Descriptors: Bacteria; Biofilms; Dental Caries; Probiotics.
Introduction
The interest in bacteriotherapy to prevent and control medical and 
oral conditions has grown remarkably in recent years. The Human Mi-
crobiome Project has provided insights that the biofilms inside and out-
side our bodies have co-evolved with mankind, and play an important 
role in maintaining health. This is also true of the oral cavity in which 
the microbiota does not play a passive role but actively contributes to 
maintaining oral health.1 In other words, the balance between beneficial 
and pathogenic bacteria is essential for stability and well-being. Howev-
er, certain ecological shifts in the microbiome allow pathogens to mani-
fest themselves and cause disease. Regarding caries, a frequent consump-
tion of fermentable carbohydrates can lead to an environment that favors 
aciduric species (e.g. mutans streptococci and lactobacilli), reducing the 
biofilm diversity and resulting in enamel demineralization. Bacterioth-
eraphy is the term used when a harmless effector strain is implanted in 
the host’s microflora to maintain or restore a natural microbiome by in-
terference and/or inhibition of other microorganisms, especially patho-
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gens. This could lead to alternative ways of fighting 
infectious diseases with less harmful side effects, 
and may also help in the treatment of disorders that 
seem to have nothing to do with bacteria, such as 
asthma, obesity and diabetes. Probiotic bacteria, de-
fined as “live microorganisms which, when admin-
istered in adequate amounts, confer a health ben-
efit on the host” (WHO), are commonly suggested 
candidates for bacteriotherapy. Whether or not such 
bacterial interference applies to dental caries is still 
an open question. Clinical evaluations of probiotic 
bacteria that are naturally specific to the mouth are 
uncommon. So far, strains isolated and developed 
mostly for gastrointestinal health have been adopted 
to conduct dental research. These strains could be 
suboptimal, considering the unique ecological envi-
ronment that exists in the oral biofilm. The aim of 
this conference paper was to summarize the current 
literature on the use of probiotic bacteria as a poten-
tial anti-caries measure. For a more comprehensive 
review, readers may refer to De Vrese and Schrezen-
meir.2
Mechanisms of action
Probiotics means “for life” and, in principle, ei-
ther naturally occurring or genetically engineered 
strains are used for intervention. The most common 
probiotic bacteria belong to the lactobacilli and bi-
fidobacteria genera, but certain strains of strepto-
cocci have also been investigated.3 Lactobacilli are 
highly acidogenic and aciduric, and grow optimally 
under slightly acidic conditions. They are considered 
a part of the normal oral flora and comprise about 
1% of the cultivable species. Bifidobacteria, on the 
other hand, occur in only minute amounts in the 
normal oral biofilm. It is important to stress, how-
ever, that not all lactic acid bacteria (or bifidobac-
teria) are probiotic and possess the ability to confer 
health benefits for the host.
Although the theory that certain bacteria may 
have beneficial effects on health was presented in 
early 1900 by Nobel Prize laureate Ilya Metchnikof, 
the mechanisms of action are still not fully under-
stood. It seems clear, however, that there are local 
(direct) as well as systemic (indirect) events that oc-
cur by regulation of the immune response. Accord-
ing to Reid,4 the potential avenues are 
• (i) co-aggregation and growth inhibition, 
• (ii) bacteriocin and hydrogen peroxide produc-
tion, 
• (iii) competitive exclusion through antagonistic 
activities on adhesion and nutrition, and, 
• (iv) immunomodulation. 
Consequently, the composition and metabol-
ic activity of the oral biofilm may be temporar-
ily modified. The effects of probiotic bacteria seem 
strain-specific, and cannot be applied directly to 
other strains. Moreover, the same strains may have 
a different effect on different individuals.5 Probiotic 
bacteria do not colonize the host permanently, but 
permanent colonization is not required for probiotic 
action to occur. Studies in feces, plaque and saliva 
clearly show that ingested probiotic bacteria are re-
covered only up to one week after termination of an 
intake.6,7
Laboratory and animal studies
Several experimental studies have recently been 
performed with the main purpose of investigating 
various biochemical properties of probiotic bacteria 
and their interaction with oral bacteria in plankton-
ic cultures or in biofilm models. For example, stud-
ies on metabolic activity,8 co-aggregation,9 growth 
inhibition,10 bacteriocin production,3 binding to 
oral structures, saliva and biofilm formation,11 have 
collectively suggested a potential role for probiotic 
bacteria in modulating the oral microbial ecology. 
Consequently, the search has started for optimal 
candidates for the major oral diseases. Nonetheless, 
the proposed strains have not yet been tested in hu-
man clinical trials.12,13 One selected candidate, how-
ever, has been evaluated in an animal model. Patho-
gen-free rats were inoculated with S. mutans and 
fed with a cariogenic diet supplemented with a heat-
killed probiotic strain (L. paracasei DSMZ16671) 
or placebo.14 The animals were sacrificed after 42 
days and a significant caries reduction (preventive 
fraction of 27%) was displayed in the test group 
compared with the controls. The authors concluded 
that the intervention appeared efficacious and safe.14
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Clinical trials with microbial 
endpoints
There are several short-term studies describing 
human interventions with probiotic bacteria with 
caries-related microbiological endpoints in saliva 
or plaque, as shown in Table 1.15-30 All used paral-
lel arms with intervention versus placebo/control, 
or a crossover design. The sample sizes were gener-
ally small and the interventions were shorter than 
1 month. A variety of vehicles for the delivery of 
the live bacteria were used, such as dairy products, 
ice cream, tablets and lozenges, and the daily dose 
ranged between 107 and 109 bacteria. With few ex-
ceptions, conventional cultivation on selective agar 
plates or simple chairside methods were employed; 
DNA-based methods were reported in only three 
papers.24,25,28 Statistically significant reductions of 
mutans streptococci in saliva or plaque were report-
ed in two thirds of all studies. However, it was not 
possible to quantify the magnitude of bacterial de-
crease, due to the frequent use of categorical scores 
from chairside bacterial tests rather than bacterial 
counts. The follow-up samplings were generally 
conducted at the termination of probiotic interven-
tion, and any information on the post-intervention 
re-growth of the suppressed target bacteria after-
wards was minimal. Interestingly, only three pa-
pers found an increase of lactobacilli after the daily 
intake of probiotic lactobacilli,17,25,28 and no study 
showed a simultaneous reduction of mutans strepto-
cocci and increase of lactobacilli. Another observa-
tion was that the vehicle or mode of delivery was of 
minor importance. Matching results were obtained 
with dairy products such as milk, yogurt, cheese 
and ice cream, as well as with conventional prepara-
tions like tablets, lozenges, powder and drops. Like-
wise, similar effects on mutans streptococci were 
obtained with probiotics derived from lactobacilli 
and bifidobacteria, using various doses. Studies with 
single strain probiotics have predominated in the lit-
erature and there has been insufficient information 
on multistrain interventions. No negative side ef-
fects following the probiotic interventions have been 
reported.
Table 1 -	Short-term	clinical	trials	with	microbial	endpoints.
First	author,	yr designa n;	age	(yr) vehicle	 timeb strain major	outcomec
Ahola,	200215 RCT 	 74;	 18–35 cheese	 3	w	 Lactobac.	mix MS↘
Nikawa,	200416 crossover 	 40;	 20 milk 2	w	 L. reuteri MS↘
Montalto,	200417 RCT 	 35;	 23–37 liquid/caps 45	d Lactobac.	mix MS→,	LB↗
Caglar,	200518 crossover 	 21;	 21–24 yogurt 2	w Bifidobacteria MS↘
Caglar,	200619 RCT 	 120;	 21–25	 tablet 2	w L. reuteri MS↘
Caglar,	200720 RCT 	 80;	 21–24 gum 3	w L. reuteri	(2	strains)d MS↘
Caglar,	200821 crossover 	 40;	 20–24 ice	cream 10	d Bifidobacteria MS↘
Caglar,	200822 RCT 	 20;	 20 lozenge 10	d L. reuteri	(2	strains)d MS↘
Cildir,	200923 crossover 	 24;	 12–16 yogurt 2	w Bifidobacteria MS↘
Lexner,	201024 RCT 	 20;	 12–15 milk 2	w L. rhamnosus	LB21 MS→
Sinkiewicz,	201025 RCT 	 23;	 18+ diet 12	w L. reuteri	(2	strains)d LB↗,	PI↘
Singh,	201126 crossover 	 40;	 12–14 ice	cream 10	d Bifido.	/	L. acidophilus MS↘
Jindal,	201127 RCT 	 150;	 7–14 powder 14	d L. rhamnosus /	Bifido. MS↘
Marttinen,201228 crossover 	 13;	 20–30 tablet 2	w L. rhamnosus /	reuteri MS→,	LB↗
Chuang,	201129 RCT 	 78;	 20–26 tablet 2	w L. paracasei	GMNL-33 MS,	LB→
Cildir,	201230 RCT 	 19;	 4–12 drops 25	d L. reuteri	(2	strains)d MS,	LB→
aRCT	=	randomized	controlled	trial,	crossover	=	randomized	crossover	trial;	bd	=	days,	w	=	weeks;	cMS↘	=	significant	decrease	in	salivary	mutans	strep-
tococci	counts,	LB↗	=	significant	increase	in	salivary	lactobacilli	counts,	PI↘	=	significant	decrease	in	plaque	index,	→	=	unchanged	salivary	counts;	dL. 
reuteri	ATCC	55730	and	ATCC	PTA	5289.
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Clinical trials with caries endpoint
Until now, three randomized controlled trials 
(RCT) using milk supplemented with L. rhamnosus 
(LB21 or GG), with caries as an endpoint, have been 
published (Table 2).31-33 The first of these studies in-
vestigated the effects of probiotic bacteria given to 
594 preschool children aged 1–6 years, and showed 
a significant reduction in caries increment in the 
probiotic milk group after 7 months, compared to 
the control group, but only in the subgroup of the 
3–4 year-olds.31 It was claimed that the 5-day-a-
week intake of probiotic milk reduced the risk of 
caries significantly (OR = 0.56). The second study 
was a cluster-randomized trial by Stecksén-Blicks 
et al.32 that lasted over 21 months. The results sug-
gested a dramatic reduction in early childhood car-
ies after daily consumption of milk supplemented 
with L. rhamnosus and 2.5  ppm fluoride, but the 
effect of the two supplements could not be individu-
alized. In the most recent study on root caries in 160 
older adults,33 the two factors, fluoride and probi-
otic bacteria, were separated into two groups, and 
then combined in a third group. Compared with the 
control group, all intervention groups showed sta-
tistically significant reversals of existing root caries 
lesions. The combination of fluoride and probiotic 
bacteria seemed more effective than the probiotic 
supplement or fluoride alone.33 Notably, no statisti-
cally significant reductions in the levels of S. mutans 
or lactobacilli were seen in any of the three clini-
cal studies, yet all three showed an obvious effect 
on caries.
Discussion
Almost all publications concerning probiotic 
therapy and oral health were published in the cur-
rent decade, and there is an obvious risk of publica-
tion bias and overrepresentation of positive findings. 
There is, however, good evidence of probiotic-in-
duced beneficial effects on the gut microbiota and 
gastro-intestinal health. Insofar as recent studies 
suggest that there are strong functional similarities 
between the gut and oral biofilms, it is reasonable 
to speculate that corresponding health-promoting 
events may occur in the oral cavity. The observa-
tions made in the two major caries trials in children 
were therefore interesting.31,32 Both studies found 
improvements in general health, along with reduc-
tions in caries risk and caries incidence, but the 
most important findings were probably those related 
to the use of less prescribed antibiotics.32,34 In fact, 
the findings may support a “metabolic domino ef-
fect” in which probiotic therapy is a link between 
oral and general health; the oral cavity influences 
and is influenced by general health. Future research 
will reveal if orally derived probiotic candidates op-
timized for oral diseases may have a similar dual 
impact.
A pertinent issue is that the mechanisms of pro-
biotic action are not fully understood. It is gener-
ally thought that there are combined local and sys-
temic effects involving adhesion, co-aggregation, 
competitive inhibition, production of organic acids 
and bacteriocin-like compounds, and immune-mod-
ulation.2,3 Although these events have been convinc-
ingly demonstrated in the laboratory environment, 
studies of complex biofilm models or in vivo are still 
scarce. Moreover, the Human Microbiome Project 
showed that 75 to 100 species of bacteria predomi-
nate in each person’s mouth, but different people 
Table 2 -	Controlled	clinical	trials	with	caries	as	endpoint.	Caries	development	compared	with	standard	milk	without	supple-
ments.
First	author,	yr designa n;	age	(yr) vehicle,	timeb	 drop-out strain caries	test/control PFc
Näse,	200131 RCT
	594;	 1–6
	164;	 3–4
	 milk,	 7	m
	 milk,	 7	m
24%
–
L. rhamnosus	GG
L. rhamnosus	GG
15%	/	19%
10%	/	23%
21%
56%
Stecksén-Blicks,	200932 CRCT 	174;		 1–5 	 milk,	21	m 25% L. rhamnosus	LB21	+	2.5	ppm	F ∆dmfs	0.4	/	1.6d 75%
Petersson,	201133 RCT 	160;	58–84 	 milk,	15	m 38% L. rhamnosus	LB21 rev	54%	/	24%e 55%
aRCT	=	randomized	controlled	trial,	CRCT	=	cluster	randomized	controlled	trial;	bm	=	months;	cPF	=	prevented	fraction;	dcaries	prevalence,	%;	eroot	caries	
reversals,	%.
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have different combinations of species, insofar as it 
was found that some of the species prevailing in one 
person’s mouth were rare in another’s mouth. Thus, 
it seems that there is no “one-size-fits-all” which 
might call for exposure to a mix of beneficial strains 
rather than to one single strain. The optimal dose 
for dental diseases is yet to be explored. Up to now, 
the adopted dose regimens have been based on gas-
tro-intestinal and pediatric health dosing standards. 
Genetically engineered strains with targeted proper-
ties are also expected to appear,35 albeit emotional 
barriers for introducing such strains, especially in 
children, have already been reported.
The fact that probiotic supplements require regu-
lar daily intakes (or at least 4–5 days per week) may 
be a challenge in terms of patient compliance and 
costs. The use of dairy products as vehicle for probi-
otic delivery is desirable from a cariological point of 
view. Non-sweetened milk, cheese and yogurt have 
high natural contents of calcium and phosphate 
that readily decrease the “critical pH” for enamel 
dissolution and enhance remineralization. Dietary 
supplements with probiotic bacteria are also a more 
economical alternative for the average consumer 
than tablets or capsules. Nevertheless, commercial 
interests come before science; there are already a 
number of probiotic oral health products available 
for the informed consumer, such as tablets, rinses 
and toothpastes, but with very limited clinical docu-
mentation, if any.
As found in the short-term trials, it seems likely 
that probiotic lactobacilli and bifidobacteria may 
exert an antagonistic effect on mutans strepto-
cocci in existing biofilms. The current understand-
ing is that enamel demineralization is a result of a 
carbohydrate-induced shift in the biofilm to aciduric 
phenotypes. Accordingly, the use of a single group 
of bacteria as a biomarker for caries development 
is only partly relevant. A short-term reduction in 
salivary mutans streptococci may not necessar-
ily be associated with either less caries or reduced 
caries risk. Attempts have been made to combine 
professional tooth cleaning and use of antibacterial 
agents preceding the bacterial interference, in or-
der to amplify the effect and or delay re-growth of 
pathogens.3 However, in a recent multicenter study, 
we failed to demonstrate a lactobacilli-induced ef-
fect on re-growth of salivary mutans streptococci 
after a full-mouth disinfection with chlorhexidine in 
healthy adults.36 On the other hand, the long-term 
study on root caries indicated that the probiotic 
supplement worked well when combined with fluo-
ride,31 and it seems reasonable to consider the use of 
bacteriotherapy as one possible adjunct to comple-
ment the existing evidence-based methods to pre-
vent and control caries.
The use of probiotics is generally considered safe, 
although some probiotic strains have been isolated 
from infections such as endocarditis.37 No adverse 
effects to oral health have been reported so far in 
clinical trials. Most recent trials were unable to dem-
onstrate increased counts of lactobacilli after the 
daily intake of probiotic bacteria. Acid production 
from probiotic lactobacilli could theoretically lead 
to increased caries risk, but clinical investigations 
of biofilm acidogenicity have not indicated that this 
would be the case.27 However, long-term studies are 
needed to firmly establish that the intake of probi-
otic supplements are more beneficial than harmful. 
Studies on selected individuals with an ecologically 
stressed biofilm and proven caries activity would 
also be helpful to fill the gaps of knowledge.
Conclusions
Bacterial interference with probiotic bacteria to 
support the stability and diversity of oral biofilms 
is gaining momentum in dentistry. Investigations in 
vitro, as well as clinical studies with bacterial end-
points, suggest that probiotic interference with the 
oral biofilm seems possible. Only a few randomized, 
controlled clinical trials reporting caries outcomes 
are available, but the connection to general health 
and the obvious caries preventive fractions are 
promising. However, further large-scale trials with 
orally derived anti-caries candidates are needed be-
fore we can say that we are ready to adopt bacte-
riotherapy for preventing and controlling caries in 
clinical practice.
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